A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer

DNA methylation status correlates with clinical outcomes of anti‐epidermal growth factor receptor (EGFR) treatment. There is a strong need to develop a simple assay for measuring DNA methylation status for the clinical application of drug selection based on it. In this study, we collected data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouchi, Kota, Takahashi, Shin, Okita, Akira, Sakamoto, Yasuhiro, Muto, Osamu, Amagai, Kenji, Okada, Takaho, Ohori, Hisatsugu, Shinozaki, Eiji, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898715/
https://www.ncbi.nlm.nih.gov/pubmed/34962023
http://dx.doi.org/10.1111/cas.15252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898715/
https://www.ncbi.nlm.nih.gov/pubmed/34962023
http://dx.doi.org/10.1111/cas.15252

Ejemplares similares